Comparative activity of ofloxacin with reference to bacterial strains isolated in in-patients and out-patients
- 1 January 1986
- journal article
- research article
- Published by Springer Nature in Infection
- Vol. 14 (S1) , S20-S25
- https://doi.org/10.1007/bf01645193
Abstract
Summary Thein vitro activity of ofloxacin, a new quinolone derivative, was compared to that of other agents commonly in use against pathogens isolated in the community and in the hospital. None of the community or hospital strains isolated from urinary tract infection showed resistance to ofloxacin, while variable resistance was demonstrable with all other oral agents. Similar results were obtained with pathogens isolated from infected wounds originating in the community and in the hospital. Among pathogens isolated from the respiratory tract, ofloxacin was most active againstHaemophilus influenzae, but less active than the penicillin-cephalosporin group againstStreptococcus pneumoniae. Ofloxacin was active against all but one(Pseudomonas aeruginosa) blood culture isolates. Of 112 strains isolated from community-acquired infections, only one strain was ofloxacin-resistant while resistance to sulphamethoxazole-trimethoprim, ampicillin and doxycycline was 34%, 42% and 30%, respectively. Among 219 pathogens originating from nosocomial infections, 3.2% were resistant to ofloxacin compared to 56% for cefazolin, to 7,2% for cefotaxime, 15,8% for piperacillin and 22,3% for gentamicin. These results suggest that ofloxacin has great therapeutic potential for the therapy of bacterial infections originating both in the community and in the hospital.Keywords
This publication has 6 references indexed in Scilit:
- Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classesAntimicrobial Agents and Chemotherapy, 1984
- The in vitro and in vivo activity of ciprofloxacinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1984
- In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agentAntimicrobial Agents and Chemotherapy, 1984
- In-vitro activity of enoxacin (CI-919), a new quinoline derivative, compared with that of other antimicrobial agentsJournal of Antimicrobial Chemotherapy, 1984
- In-vitro activity of enoxacin, ofloxacin, norfloxacin and nalidixic acidJournal of Antimicrobial Chemotherapy, 1984
- In vitro and in vivo activity of DL-8280, a new oxazine derivativeAntimicrobial Agents and Chemotherapy, 1982